Access Cancer Care India: affordable, integrated multi-cancer early detection to improve equitable cancer outcomes
Access Cancer Care India: affordable, integrated multi-cancer early detection to improve equitable cancer outcomes
批准号:
MR/W023903/1
负责人:
Richard Sullivan
金额:
$229.84万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Of the 1.3 billion population of India more than 70% live in the rural areas. Cancer has a catastrophic impact on the rural men and women of India, the vast majority of whom are socio-economically disadvantaged with one fourth live below national poverty line. Studies have shown that among the rural population in India expenditure on cancer treatment is among the highest for any disease due to the advanced presentation. The cost for treating advanced and metastatic disease are much higher than early stage disease. Treatment is financed mostly through borrowings, sale of assets and contributions from friends and relatives. Over 60% of the households who seek care from the private sector incur catastrophic out of pocket expenditure. Fatality rates are also significantly higher for the common cancers like breast and oral cancers in rural compared to the urban populations.2 Late presentation with more expensive disease coupled to nascent universal health coverage to protect against catastrophic expenditure typifies the 'double burden' not only in India but across the world. Improving the implementation of affordable early detection services to cancer coupled to addressing downstream cancer pathways at provider level is key to reducing such inequalities.A strong and responsive cancer health system is necessary to ensure that the screen positive (in presence of a screening programme) and/or symptomatic individuals have access to prompt diagnosis and those detected with cancer have access to appropriate treatment. Rural population in India are socio-economically disadvantaged and vulnerable to huge inequity in cancer care.3 Our hypothesis is that improving their participation to the cancer early detection pathway through careful investigation into the implementation barriers at the levels of individuals, providers and systems to design strategies and policies that are evidence and context-specific based, will lead to better outcomes.This study focuses on implementation research for a well-validated, integrated early detection interventional approach for cancer (secondary prevention) in the context of a complex lower middle- income country, India. The three states for the study provide different and comparative implementation ecosystems to dissect out critical issues and barriers (logistical, political, social and economic) to support national scale up and inform other comparable countries globally. This intervention targets three site-specific cancers - oral, cervical and breast - that, combined are responsible for 28% of premature mortality in India and 12% globally, in particular for women. Scaling up these proven secondary prevention interventions would significantly address 1/3rd reduction in premature mortality as part of SDG 3.4, and our focus on the most vulnerable populations (the rural populations in some of the hard to reach areas in India) will ensure this approach meets WHO's ambition of expanding Universal Health Coverage to a billion population.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41591-022-01738-x
发表时间:
2022-04
期刊:
NATURE MEDICINE
影响因子:
82.9
作者:
[Pramesh, C. S., Badwe, Rajendra A., Bhoo-Pathy, Nirmala, Booth, Christopher M., Chinnaswamy, Girish, Dare, Anna J., de Andrade, Victor Piana, Hunter, David J., Gopal, Satish, Gospodarowicz, Mary, Gunasekera, Sanjeeva, Ilbawi, Andre, Kapambwe, Sharon, Kingham, Peter, Kutluk, Tezer, Lamichhane, Nirmal, Mutebi, Miriam, Orem, Jackson, Parham, Groesbeck, Ranganathan, Priya, Sengar, Manju, Sullivan, Richard, Swaminathan, Soumya, Tannock, Ian F., Tomar, Vivek, Vanderpuye, Verna, Varghese, Cherian, Weiderpass, Elisabete]
通讯作者:
Weiderpass, Elisabete
DOI:
10.1200/go.22.00060
发表时间:
2022-07
期刊:
JCO global oncology
影响因子:
4.5
作者:
[]
通讯作者:
DOI:
10.1200/go.22.00034
发表时间:
2022-06
期刊:
JCO global oncology
影响因子:
4.5
作者:
[]
通讯作者:
"Iraqibacter": Exploring the Links Between War and Antimicrobial Resistance
-
批准号:MR/R014914/1
-
项目类别:Research Grant
-
资助金额:$9.73万
-
财政年份:2018
-
负责人:Richard Sullivan
-
依托单位:
GCRF RESEARCH FOR HEALTH IN CONFLICT (R4HC-MENA): developing capability, partnerships and research in the Middle and Near East (MENA)
-
批准号:ES/P010962/1
-
项目类别:Research Grant
-
资助金额:$761.78万
-
财政年份:2017
-
负责人:Richard Sullivan
-
依托单位:
Comparison of traditional vs. virtual simulation-enhanced training for scaling the cervical cancer surgery workforce in Zambia
-
批准号:MR/P025420/1
-
项目类别:Research Grant
-
资助金额:$69.07万
-
财政年份:2017
-
负责人:Richard Sullivan
-
依托单位:
Minority Resource Center of Excellence
-
批准号:8713644
-
项目类别:Standard Grant
-
资助金额:$7.5万
-
财政年份:1987
-
负责人:Richard Sullivan
-
依托单位:
Establishment of a Magnetic Resonance Research Group For TheStudy of Molecular Structure and Dynamics
-
批准号:8405345
-
项目类别:Standard Grant
-
资助金额:$24.84万
-
财政年份:1984
-
负责人:Richard Sullivan
-
依托单位:
Conformations of Thioureas and Their Sbcl5 and Bf3 Adducts
-
批准号:7509296
-
项目类别:Standard Grant
-
资助金额:$2.4万
-
财政年份:1975
-
负责人:Richard Sullivan
-
依托单位:
Research on Equipment Technology Utilized By Local Government: Street Cleaning
-
批准号:7420419
-
项目类别:Standard Grant
-
资助金额:$25.7万
-
财政年份:1974
-
负责人:Richard Sullivan
-
依托单位:
国内基金
海外基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
-
批准号:81673007
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2016
-
负责人:金时
-
依托单位: